Evidence map›Paper›PMID 37253603›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model.

Olivier Landry, Arnaud François, Méryl-Farelle Oye Mintsa Mi-Mba, Marie-Therese Traversy, Cyntia Tremblay, Vincent Emond, David A Bennett, Karen H Gylys, Joseph D Buxbaum, Frédéric Calon

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Convergence of autism proteins at the cilium.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Blood-based multivariate methylation risk score for cognitive impairment and dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Olivier LandryFaculté de pharmacie, Université Laval, Quebec G1V 0A6, Quebec, Canada.ORCID 0000-0002-8757-9857
Arnaud FrançoisFaculté de pharmacie, Université Laval, Quebec G1V 0A6, Quebec, Canada.
Méryl-Farelle Oye Mintsa Mi-MbaFaculté de pharmacie, Université Laval, Quebec G1V 0A6, Quebec, Canada.
Marie-Therese TraversyFaculté de pharmacie, Université Laval, Quebec G1V 0A6, Quebec, Canada.
Cyntia TremblayAxe Neurosciences, Centre de recherche du CHU de Québec-Université Laval, Quebec G1V 4G2, Quebec, Canada.
Vincent EmondAxe Neurosciences, Centre de recherche du CHU de Québec-Université Laval, Quebec G1V 4G2, Quebec, Canada.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612.
Karen H GylysSchool of Nursing, University of California, Los Angeles, California 90095.ORCID 0000-0001-8218-9684
Joseph D BuxbaumSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York 10029, New York.
Frédéric CalonFaculté de pharmacie, Université Laval, Quebec G1V 0A6, Quebec, Canada Frédéric.Calon@crchul.ulaval.ca.
Centre hospitalier de l'Université Laval · CAIcahn School of Medicine at Mount Sinai · USRush University Medical Center · USUniversity of California, Los Angeles · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI LEURGANS, SUE E. · 1991 to 2020
$49.1M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819
6 · The paper itself

Abstract

Synaptic loss is intrinsically linked to Alzheimer's disease (AD) neuropathology and symptoms, but its direct impact on clinical symptoms remains elusive. The postsynaptic protein Shank3 (SH3 and multiple ankyrin repeat domains) is of particular interest, as the loss of a single allele of the

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsCognitionDisease Models, AnimalFemaleHumansMaleMiceMice, TransgenicMicrofilament ProteinsNerve Tissue Proteinstau ProteinsAmyloid beta-PeptidesAmyloid beta-Protein PrecursorMicrofilament ProteinsNerve Tissue ProteinsShank3 protein, mousetau ProteinsagingAlzheimer's diseasemouse modelneurodegenerative diseaseShank3synaptic plasticity

Identifiers

PMID37253603
PMCPMC10312061
OpenAlexW4378782599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.